Abstract:Background: Cisplatin is an extensively used anti-neoplastic agent for the treatment of various solid tumors. However, a high incidence of severe ototoxicity is accompanied by its use in the clinic. Currently, no drugs or therapeutic strategies have been approved for the treatment of cisplatin-induced ototoxicity by the FDA. Purpose: The purpose of this study was to investigate the otoprotective effects of dexamethasone (DEX)-loaded silk-polyethylene hydrogel (DEX-SILK) following round window membrane administration in the cisplatin-induced ototoxicity mouse model. Methods: The morphology, gelation kinetics, viscosity and secondary structure of the DEX-SILK hydrogel were analyzed. DEX concentration in the perilymph was tested at different time points following hydrogel injection on the RWM niche. Cultured cells (HEI-OC1), organ of Corti explants (C57/BL6, P0-2), and cisplatin-induced hearing loss mice model (C57/BL6) were used as in vitro and in vivo models for investigating the otoprotective effects of DEX-SILK hydrogel against cisplatin. Results: Encapsulation of DEX with a loading of 8% (w/v) did not significantly change the silk gelation time, and DEX was evenly distributed in the Silk-PEG hydrogel as visualized by scanning electron microscopy (SEM). The concentration of Silk majorly influenced DEX distribution, morphological characteristics, viscosity, and gelation time. The optimized DEX-SILK hydrogel (8% w/v loading, 15% silk concentration, 10 μl) was administered directly onto the RWM of the guinea pigs. The DEX concentration in the perilymph was maintained above 1 μg/ml for at least 21 days for the DEX-SILK, while it was maintained for less than 6 h in the control sample of free DEX. DEX-SILK (5-60 ng/ml) exhibited significant protective effects against cisplatin-induced cellular ototoxicity and notably reduced the production of reactive oxygen species (ROS). Eventually, pretreatment with DEX-SILK effectively preserved outer hair cells in the cultured organ of Corti explants and demonstrated significant hearing protection at 4, 8, and 16 kHz in the cisplatin-induced hearing loss mice as compared to the effects noted following pretreatment with DEX. Conclusion: These results demonstrated the clinical value of DEX-SILK for the therapy of cisplatin-induced ototoxicity.

The Preparation of Dexamethasone Sodium Phosphate Multivesicular Liposomes Thermosensative Hydrogel and Its Impact on Noise-Induced Hearing Loss in the Guinea Pigs.

Therapeutic efficacy of middle ear administration of dexamethasone on impulsive noise-induced hearing loss: an experimental study

Therapeutic Efficacy of Topical Application of Dexamethasone to the Round Window Niche after Acoustic Trauma Caused by Intensive Impulse Noise in Guinea Pigs

A Single Dose of Dexamethasone Encapsulated in Polyethylene Glycol-Coated Polylactic Acid Nanoparticles Attenuates Cisplatin-Induced Hearing Loss Following Round Window Membrane Administration.

Assessment of the efficacy of a local steroid rescue treatment administered 2 days after a moderate noise-induced trauma in guinea pig

Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection

Effect of Dexmedetomidine on Noise-Induced Hearing Loss in Guinea Pigs

Dexamethasone Loaded Nanoparticles Exert Protective Effects Against Cisplatin-induced Hearing Loss by Systemic Administration

Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel

[Dexamethasone Pharmacokinetics in Perilymph of Guinea Pig after Different Topical Administrations].

Study the Pharmacokinetics of Dexamethasone in the Perilymph after the Sodium Alginate Dexamethasone Gel Transtympanic Administration in Vivo

Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane

Protective effect of dexmedetomidine on noise-induced hearing loss.

Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity

Silk-coated dexamethasone non-spherical microcrystals for local drug delivery to inner ear

Study on Dexamethasone Thermosensistivie in Situ Gel for Treating Deafness

The Protective Effects of Intratympanic Dexamethasone to Prevent Cisplatin Ototoxicity

Mastoid approach for local drug delivery to the inner ear for treating hearing loss

Microfluidic Preparation of Gelatin Methacryloyl Microgels As Local Drug Delivery Vehicles for Hearing Loss Therapy.

Hydrogel Matrix Containing Microcarriers for Dexamethasone Delivery to Protect Against Cisplatin-Induced Hearing Loss

Biopolymer Lipid Hybrid Microcarrier for Transmembrane Inner Ear Delivery of Dexamethasone